Bulk Pharmaceutical API Sources for ZIDOVUDINE

Bulk Pharmaceutical API Sources for ZIDOVUDINE

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		A2169_SIGMA
Calbiochem		194348
NovoSeek		35370
Vitas-M Laboratory		STK801891

Bulk Active Pharmaceutical Ingredient (API) Sources for: Zidovudine

Last updated: July 27, 2025

Introduction

Zidovudine, also known as AZT (azidothymidine), stands as a cornerstone in antiretroviral therapy, notably in the treatment of HIV/AIDS. Since its approval by the FDA in 1987, zidovudine has played a pivotal role in reducing HIV transmission and managing disease progression. As demand for antiretroviral medications increases globally, ensuring reliable and high-quality sources of bulk zidovudine API is critical for pharmaceutical manufacturers and healthcare providers. This article provides a comprehensive overview of the key bulk API suppliers for zidovudine, examining their manufacturing capabilities, regulatory compliance, supply reliability, and market positioning.

---

Overview of Zidovudine API Market

The market for zidovudine API is predominantly concentrated among a select group of manufacturers based in India, China, and other emerging markets. The increasing need for affordable antiretroviral drugs in developing countries has fueled supply expansion within these regions. Nevertheless, sourcing zidovudine APIs requires careful assessment of quality standards, regulatory approvals, and supply chain stability due to the complex manufacturing process and stringent quality controls necessary for pharmaceutical APIs.

---

Leading Suppliers of Zidovudine API

1. CIPLA Ltd. (India)

CIPLA, a prominent pharmaceuticals manufacturer headquartered in Mumbai, India, supplies high-quality zidovudine API to international markets. The company maintains extensive in-house manufacturing facilities compliant with WHO and cGMP standards, ensuring quality and consistency.

• Manufacturing Facilities & Capabilities: CIPLA operates multiple facilities equipped with advanced process controls and purification steps to meet USP, Indian Pharmacopoeia, and international standards.
• Regulatory Compliance: CIPLA’s APIs are often registered with major regulatory bodies including the US FDA, EMA, and WHO prequalification programs, making their zidovudine API suitable for global distribution.
• Supply Reliability: With an established export network, CIPLA maintains regular supply commitments and has a history of consistently meeting bulk order demands.

2. Hetero Drugs Ltd. (India)

Hetero is among the leading Indian pharmaceutical companies involved in the production of antiretroviral APIs, including zidovudine.

• Manufacturing Expertise: Their facilities are compliant with cGMP and include integrated processes from synthesis to purification, ensuring high purity levels.
• Regulatory Portfolio: Hetero APIs are registered with various regulatory authorities, including US FDA and WHO, facilitating approvals for global markets.
• Market Presence: Known for its competitive pricing and reliable supply chain, Hetero supplies zidovudine API to generic drug manufacturers worldwide.

3. Sun Pharmaceutical Industries Ltd. (India)

Sun Pharma, a significant player in the global pharmaceutical landscape, manufactures zidovudine API for export markets.

• Quality Standards: Their API manufacturing units adhere to international quality benchmarks, including cGMP compliance.
• Supply Chain & Logistics: Sun Pharma's extensive distribution network ensures consistent delivery and availability of zidovudine API.
• Regulatory Approvals: Their APIs often meet US FDA, European EMA, and World Health Organization standards, enabling their products to serve a broad spectrum of markets.

4. Zhejiang Hisun Pharmaceuticals (China)

Chinese pharmaceutical companies like Zhejiang Hisun Pharmaceuticals have emerged as key zidovudine API suppliers, especially for markets seeking competitively priced APIs.

• Manufacturing Capabilities: Hisun employs advanced synthetic processes and purification techniques aligned with international standards.
• Quality Assurance: They have obtained various quality certifications, including ISO and GMP certificates.
• Market Reach: Their APIs are exported to Africa, Southeast Asia, and Latin America, aligning with their strategic focus on emerging markets.

5. Zhejiang Tianyu Pharmaceutical Co. Ltd. (China)

Another Chinese API producer, Zhejiang Tianyu, contributes to the global zidovudine supply chain.

• Production Standards: Their manufacturing facilities follow cGMP practices and hold multiple certifications.
• Cost-Effectiveness: Tianyu offers competitive pricing, making their zidovudine APIs attractive for generics manufacturers.
• Regulatory Engagement: They actively seek WHO prequalification and other regulatory registrations to expand their global reach.

---

Key Considerations When Sourcing Zidovudine API

Regulatory Compliance & Quality Assurance

Choosing suppliers with proven compliance to cGMP, ISO, and WHO standards is essential for ensuring API safety, efficacy, and regulatory acceptance. It minimizes risks of batch rejection and regulatory penalties.

Manufacturing Capacity & Supply Reliability

Assessing the supplier’s production scale and history of plant operations ensures consistent supply. Longevity in the market and export track records serve as indicators of reliability.

Pricing & Economic Factors

Cost competitiveness remains vital, especially for programs in resource-limited settings. However, this must be balanced against quality and regulatory compliance to avoid supply chain disruptions.

Geographical & Political Stability

Political stability and export policies influence the ability to reliably source APIs. Diversification across suppliers and regions mitigates risks associated with regional disruptions.

---

Regulatory and Market Dynamics

Globally, zidovudine APIs are subject to rigorous quality audits and documentation requirements. Suppliers often pursue international accreditations like WHO prequalification and US FDA registration to access markets in Africa, Asia, and Latin America. Manufacturers with such clearances enjoy competitive advantages, including wider distribution channels and enhanced trust among procurement agencies.

The evolving landscape of HIV treatment guidelines, with a shift toward fixed-dose combinations and second-generation antiretrovirals, may influence demand dynamics for zidovudine. Yet, its continued use in combination therapies sustains steady demand for high-quality APIs from reliable sources.

---

Future Outlook

The zidovudine API market is expected to remain stable, given its essential role in HIV treatment. Emerging markets will continue to seek affordable, high-quality sourcing options, emphasizing the importance of compliant manufacturers in India and China. The push for increased regulatory oversight, quality control, and capacity expansion will further shape supplier profiles.

Innovations in synthetic processes, green chemistry, and manufacturing automation are poised to enhance API quality, reduce costs, and improve supply chain resilience. Suppliers investing in such advancements will likely secure dominant positions in this niche.

---

Key Takeaways

• Top Suppliers: CIPLA, Hetero, Sun Pharma, Zhejiang Hisun, and Zhejiang Tianyu are leading zidovudine API manufacturers, distinguished by their compliance with international standards and export experience.
• Quality and Compliance Priority: Ensuring suppliers possess WHO prequalification or equivalent certifications is critical for regulatory approval and safety assurance.
• Supply Chain Reliability: Selecting manufacturers with proven production capacity and stable logistics processes minimizes risk.
• Market Dynamics: The global demand for zidovudine APIs remains steady, driven by resource-limited countries' HIV/AIDS treatment programs.
• Future Trends: Emphasis on quality, regulatory adherence, and manufacturing innovation will continue to influence supplier selection and market competition.

---

FAQs

1. What are the primary regions supplying zidovudine API globally?
India and China dominate the production of zidovudine APIs, offering a mix of quality, cost-effectiveness, and regulatory compliance suitable for global markets.

2. How can buyers ensure the quality of zidovudine APIs?
Verification of cGMP certification, WHO prequalification, and regulatory approvals such as US FDA registration are essential indicators of API quality.

3. Are there any emerging suppliers for zidovudine API?
Emerging manufacturers in Southeast Asia and Africa are increasingly investing in API production, aiming to diversify supply sources and reduce dependence on traditional markets.

4. What regulatory considerations exist for importing zidovudine API?
Importing authorities require documentation of quality certifications, batch release standards, and compliance with local pharmacopoeia standards, often necessitating suppliers to have recognized international certifications.

5. How might future innovations impact zidovudine API sourcing?
Advancements in green chemistry and process efficiencies could lower costs and enhance sustainability, making APIs more accessible and improving supply chain resilience.

---

References

[1] U.S. Food and Drug Administration. "FDA-approved drugs and APIs." FDA database, 2022.
[2] World Health Organization. "Prequalification of suppliers of drugs and vaccines." WHO PQ Program, 2022.
[3] IQVIA Institute. "Global Trends in Antiretroviral Drug Markets." 2022.
[4] Pharmaceuticalline. "Top API Manufacturers for Antiretrovirals." Industry Report, 2023.
[5] Pharma Intelligence. "Emerging API Suppliers in Asia." Market Watch, 2022.